Zachary J Schlader1, Craig G Crandall. 1. Institute for Exercise and Environmental Medicine, Texas Health Presbyterian Hospital of Dallas, 7232 Greenville Ave, Dallas, TX, 75231, USA.
Abstract
PURPOSE: To test the hypothesis that those who are highly tolerant to lower body negative pressure (LBNP) while normothermic are also highly tolerant to this challenge while hyperthermic. METHODS:Sixty pairs of normothermic and hyperthermic LBNP tests to pre-syncope were evaluated. LBNP tolerance was quantified via the cumulative stress index (CSI), which is calculated as the sum of the product of the LBNP level and the duration of each level until test termination (i.e., 20 mmHg × 3 min + 30 mmHg × 3 min, etc.). CSI was compared between normothermic and hyperthermic trials. Internal and skin temperatures, heart rate, and arterial pressure were measured throughout. RESULTS:Hyperthermia reduced (P < 0.001) CSI from 997 ± 437 to 303 ± 213 mmHg min. There was a positive correlation between normothermic and hyperthermic LBNP tolerance (R (2) = 0.38; P < 0.001). As a secondary analysis, the 20 trials with the highest LBNP tolerance while normothermic were identified (indicated as the HIGH group; CSI 1,467 ± 356 mmHg min), as were the 20 trials with the lowest normothermic tolerance (indicated as the LOW group; CSI 565 ± 166 mmHg min; P < 0.001 between groups). While hyperthermia unanimously reduced CSI in both HIGH and LOW groups, in this hyperthermic condition CSI was ~threefold higher in the HIGH group (474 ± 226 mmHg min) relative to the LOW group (160 ± 115 mmHg min; P < 0.001). CONCLUSIONS:LBNP tolerance while hyperthermic is related to normothermic tolerance and, associated with this finding, those who have a high LBNP tolerance while normothermic remain relatively tolerant when hyperthermic.
RCT Entities:
PURPOSE: To test the hypothesis that those who are highly tolerant to lower body negative pressure (LBNP) while normothermic are also highly tolerant to this challenge while hyperthermic. METHODS: Sixty pairs of normothermic and hyperthermic LBNP tests to pre-syncope were evaluated. LBNP tolerance was quantified via the cumulative stress index (CSI), which is calculated as the sum of the product of the LBNP level and the duration of each level until test termination (i.e., 20 mmHg × 3 min + 30 mmHg × 3 min, etc.). CSI was compared between normothermic and hyperthermic trials. Internal and skin temperatures, heart rate, and arterial pressure were measured throughout. RESULTS:Hyperthermia reduced (P < 0.001) CSI from 997 ± 437 to 303 ± 213 mmHg min. There was a positive correlation between normothermic and hyperthermic LBNP tolerance (R (2) = 0.38; P < 0.001). As a secondary analysis, the 20 trials with the highest LBNP tolerance while normothermic were identified (indicated as the HIGH group; CSI 1,467 ± 356 mmHg min), as were the 20 trials with the lowest normothermic tolerance (indicated as the LOW group; CSI 565 ± 166 mmHg min; P < 0.001 between groups). While hyperthermia unanimously reduced CSI in both HIGH and LOW groups, in this hyperthermic condition CSI was ~threefold higher in the HIGH group (474 ± 226 mmHg min) relative to the LOW group (160 ± 115 mmHg min; P < 0.001). CONCLUSIONS: LBNP tolerance while hyperthermic is related to normothermic tolerance and, associated with this finding, those who have a high LBNP tolerance while normothermic remain relatively tolerant when hyperthermic.
Authors: C G Crandall; T E Wilson; J Marving; M Bundgaard-Nielsen; T Seifert; T L Klausen; F Andersen; N H Secher; B Hesse Journal: J Physiol Date: 2012-01-04 Impact factor: 5.182
Authors: Alexander P Welles; Mark J Buller; Lee Margolis; Demetri Economos; Reed W Hoyt; Mark W Richter Journal: Mil Med Date: 2013-10 Impact factor: 1.437
Authors: Matthew S Ganio; Morten Overgaard; Thomas Seifert; Niels H Secher; Pär I Johansson; Martin A S Meyer; Craig G Crandall Journal: Am J Physiol Heart Circ Physiol Date: 2012-02-24 Impact factor: 4.733
Authors: Daniel Gagnon; Steven A Romero; Hai Ngo; Paula Y S Poh; Craig G Crandall Journal: Am J Physiol Regul Integr Comp Physiol Date: 2016-12-21 Impact factor: 3.619
Authors: Mu Huang; R Matthew Brothers; Matthew S Ganio; Rebekah A I Lucas; Matthew N Cramer; Gilbert Moralez; Victor A Convertino; Craig G Crandall Journal: Exp Physiol Date: 2018-07-23 Impact factor: 2.969
Authors: Mu Huang; Joseph C Watso; Luke N Belval; Frank A Cimino; Mads Fischer; Caitlin P Jarrard; Joseph M Hendrix; Carmen Hinojosa Laborde; Craig G Crandall Journal: Am J Physiol Regul Integr Comp Physiol Date: 2021-12-01 Impact factor: 3.619
Authors: Joseph C Watso; Luke N Belval; Frank A Cimino; Bonnie D Orth; Joseph M Hendrix; Mu Huang; Elias Johnson; Josh Foster; Carmen Hinojosa-Laborde; Craig G Crandall Journal: Am J Physiol Heart Circ Physiol Date: 2022-04-22 Impact factor: 5.125
Authors: Zachary J Schlader; Eric Rivas; Babs R Soller; Victor A Convertino; Craig G Crandall Journal: Am J Physiol Regul Integr Comp Physiol Date: 2014-07-16 Impact factor: 3.619
Authors: Daniel Gagnon; Zachary J Schlader; Amy Adams; Eric Rivas; Jane Mulligan; Gregory Z Grudic; Victor A Convertino; Jeffrey T Howard; Craig G Crandall Journal: Shock Date: 2016-09 Impact factor: 3.454
Authors: Paula Y S Poh; Daniel Gagnon; Steven A Romero; Victor A Convertino; Beverley Adams-Huet; Craig G Crandall Journal: Shock Date: 2016-09 Impact factor: 3.454
Authors: Zachary J Schlader; Daniel Gagnon; Eric Rivas; Victor A Convertino; Craig G Crandall Journal: Exp Physiol Date: 2015-07-15 Impact factor: 2.969